Sign up
Pharma Capital
Market: CSE
52-week High/Low: C$0.41 / C$0.04
Sector: Pharma & Biotech
Market Cap: C$3.46M

LeanLife has developed a patented process to isolate omega-3 fatty acids from flax (linen) seeds. LeenLife omega products are in the form of an oil or a powder with a purity in excess of 98%. The products are sold on-line or as a food additive to food processors making such items as bread, noodles and milk products.

LeanLife Health

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in LeanLife Health

LeanLife Health Snapshot

LeenLife Pharma International Inc.

Suite 380 – 580 Hornby Street
Vancouver, BC  V6C 3B6

Phone: +1 604-764-0518.

View full LLP profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.